CRISPR Therapeutics
Data Breaches, Cyber Attacks and Security Report

https://crisprtx.com  ᛫ 
Last updated February 25, 2020

About CRISPR Therapeutics

Company Overview

Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna and colleagues at University of California. The company has partnerships with Novartis and Regeneron.

Valuation

Employees

58

CEO

Location

Basel, BS, Switzerland.

Data Breaches and Security News

CRISPR Therapeutics Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely CRISPR Therapeutics is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for CRISPR Therapeutics

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare CRISPR Therapeutics's security performance with other companies